Eli Lilly and Company: Dyslipidemias trials
The registry lists 10 Dyslipidemias studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 1 5Phase 2 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT06007651Phase 1Results posted
- A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsCompletedNCT05563246Phase 2Results posted
- A Study of LY3561774 in Participants With Mixed DyslipidemiaCompletedNCT05256654Phase 2Results posted
- A Study to Evaluate LY3202328 in Overweight Healthy Participants and DyslipidemiaCompletedNCT02714569Phase 1Results posted
- A Study of Evacetrapib in Participants With Abnormal CholesterolCompletedNCT02168803Phase 1Results posted
- A Study of LY2484595 in Japanese SubjectsCompletedNCT01375075Phase 2Results posted
- A Study of LY2484595 in Patients With High LDL-C or Low HDL-CCompletedNCT01105975Phase 2Results posted
- A Study of LY3561774 in Participants With DyslipidemiaCompletedNCT04644809Phase 1
- A Study of LY3475766 in Healthy ParticipantsCompletedNCT04052594Phase 1
- A Study in People With Abnormal Fat Levels in the BloodCompletedNCT00116519Phase 2